Cargando…

Expression Microarray Meta-Analysis Identifies Genes Associated with Ras/MAPK and Related Pathways in Progression of Muscle-Invasive Bladder Transition Cell Carcinoma

The effective detection and management of muscle-invasive bladder Transition Cell Carcinoma (TCC) continues to be an urgent clinical challenge. While some differences of gene expression and function in papillary (Ta), superficial (T1) and muscle-invasive (≥T2) bladder cancers have been investigated,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ewald, Jonathan A., Downs, Tracy M., Cetnar, Jeremy P., Ricke, William A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3562183/ https://www.ncbi.nlm.nih.gov/pubmed/23383328 http://dx.doi.org/10.1371/journal.pone.0055414

Ejemplares similares

Selective bladder preservation for muscle-invasive transitional cell carcinoma of the urinary bladder
por: Michaelson, M D, et al.
Publicado: (2004)

Collagen stiffness promoted non-muscle-invasive bladder cancer progression to muscle-invasive bladder cancer
por: Zhu, Huier, et al.
Publicado: (2019)

Progress on Ras/MAPK Signaling Research and Targeting in Blood and Solid Cancers
por: Dillon, Martha, et al.
Publicado: (2021)

Proteomics research on muscle-invasive bladder transitional cell carcinoma
por: Niu, Hai Tao, et al.
Publicado: (2011)

The Bladder Microbiome Is Associated with Epithelial–Mesenchymal Transition in Muscle Invasive Urothelial Bladder Carcinoma
por: Li, Wei Tse, et al.
Publicado: (2021)

Clinicopathological Criteria Predictive of Recurrence Following Bacillus Calmette-Guérin Therapy Initiation in Non–Muscle-Invasive Bladder Cancer: Retrospective Cohort Study
por: Plasek, Joseph, et al.
Publicado: (2021)

Exploiting codon usage identifies intensity-specific modifiers of Ras/MAPK signaling in vivo
por: Sawyer, Jessica K., et al.
Publicado: (2020)

RAS MAPK inhibitors deregulation in leukemia
por: Pasmant, Eric, et al.
Publicado: (2015)

RASAL2, a RAS GTPase-activating protein, inhibits stemness and epithelial–mesenchymal transition via MAPK/SOX2 pathway in bladder cancer
por: Hui, Ke, et al.
Publicado: (2017)

MicroRNA Expression Profile Identifies High Grade, Non-Muscle-Invasive Bladder Tumors at Elevated Risk to Progress to an Invasive Phenotype
por: Lenherr, Sara M., et al.
Publicado: (2017)

Aurora kinase A interacts with H-Ras and potentiates Ras-MAPK signaling
por: Umstead, MaKendra, et al.
Publicado: (2017)

TP53 codon 72 polymorphism is associated with FGFR3 and RAS mutation in non-muscle-invasive bladder cancer
por: Kawahara, Takashi, et al.
Publicado: (2019)

HER2/neu overexpression in the development of muscle-invasive transitional cell carcinoma of the bladder
por: Latif, Z, et al.
Publicado: (2003)

Lymph node density in muscle-invasive transitional cell carcinoma of the urinary bladder; De novo versus progressive disease
por: Elabbady, Ahmed, et al.
Publicado: (2017)

Profiling the Biological Characteristics and Transitions through Upper Tract Tumor Origin, Bladder Recurrence, and Muscle-Invasive Bladder Progression in Upper Tract Urothelial Carcinoma
por: Shigeta, Keisuke, et al.
Publicado: (2022)

Bladder Sparing Approaches for Muscle-Invasive Bladder Cancers
por: El-Taji, Omar M. S., et al.
Publicado: (2016)

Bladder Preservation for Muscle Invasive Bladder Cancer
por: Mirza, Arafat, et al.
Publicado: (2016)

Patterns of Bladder Preservation Therapy Utilization for Muscle-Invasive Bladder Cancer
por: Rose, Tracy L., et al.
Publicado: (2016)

Down regulated oncogene KIF2C inhibits growth, invasion, and metastasis of hepatocellular carcinoma through the Ras/MAPK signaling pathway and epithelial-to-mesenchymal transition
por: Mo, Shutian, et al.
Publicado: (2022)

Side Population in Human Non-Muscle Invasive Bladder Cancer Enriches for Cancer Stem Cells That Are Maintained by MAPK Signalling
por: Hepburn, Anastasia C., et al.
Publicado: (2012)

Bladder preservation versus radical cystectomy in transitional cell carcinoma and squamous cell carcinoma muscle invasive bladder cancer
por: Mohamed, Dalia O., et al.
Publicado: (2021)

Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancer
por: Zieger, Karsten, et al.
Publicado: (2009)

FOXM1 predicts disease progression in non-muscle invasive bladder cancer
por: Rinaldetti, Sebastien, et al.
Publicado: (2018)

Prediction of progression to muscle-invasive disease in patients with high-risk bladder cancer
por: Oszczudlowski, Maciej, et al.
Publicado: (2018)

Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladder
por: Hafeez, S, et al.
Publicado: (2015)

Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladder
por: Hafeez, S, et al.
Publicado: (2016)

Urothelial cells undergo epithelial-to-mesenchymal transition after exposure to muscle invasive bladder cancer exosomes
por: Franzen, C A, et al.
Publicado: (2015)

Systems Drug Design for Muscle Invasive Bladder Cancer and Advanced Bladder Cancer by Genome-Wide Microarray Data and Deep Learning Method with Drug Design Specifications
por: Su, Po-Wei, et al.
Publicado: (2022)

ras gene alterations in invasive and non-invasive rat bladder carcinomas induced by N-methyl-N-nitrosourea.
por: Yura, Y., et al.
Publicado: (1991)

The Ras/MAPK Pathway Is Required for Generation of iNKT Cells
por: Hu, Taishan, et al.
Publicado: (2011)

Loss of heterozygosity on chromosome 18q is associated with muscle-invasive transitional cell carcinoma of the bladder.
por: Brewster, S. F., et al.
Publicado: (1994)

Clinical experience of MRI in two dogs with muscle-invasive transitional cell carcinoma of the urinary bladder
por: LEE, Kija, et al.
Publicado: (2016)

Predictors of Outcome of Non–Muscle-Invasive and Muscle-Invasive Bladder Cancer
por: Youssef, Ramy F., et al.
Publicado: (2011)

Ras/MAPK Modifier Loci Revealed by eQTL in Caenorhabditis elegans
por: Sterken, Mark G., et al.
Publicado: (2017)

Hyper-active RAS/MAPK introduces cancer-specific mitotic vulnerabilities
por: Herman, Jacob A., et al.
Publicado: (2022)

Where are we with bladder preservation for muscle-invasive bladder cancer in 2017?
por: Smelser, Woodson Wade, et al.
Publicado: (2017)

UBN2 promotes tumor progression via the Ras/MAPK pathway and predicts poor prognosis in colorectal cancer
por: Zhao, Ya-li, et al.
Publicado: (2019)

Identifying the Molecular Mechanisms Contributing to Progression, Metastasis, and Death in Low-grade Non–muscle-invasive Bladder Cancer: A Case Report
por: Weiß, Sarah, et al.
Publicado: (2021)

Abstract: Somatic MAP2K1 Mutations in Arteriovenous Malformation Constitutively Activate the RAS/MAPK Pathway
por: Goss, Jeremy A., et al.
Publicado: (2018)

The value of molecular markers in classification and prediction of progression in non-muscle-invasive bladder cancer
por: Pan, Chin-Chen
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3ff5kk938g29m8e4rjuuatquk2